Home
About
Why D4DPR?
Strategic Vision
Platform of Regulations
Leadership
D4DPR Experts
D4DPR Updates
Advocacy
Media
Expert Testimony
Coalition Partners
Education
Cannabis Curriculums
Regulation & Public Health
Harms of Prohibition
Myths, Risks & Uncertainties
Resources
Ask a Question
Regulation
Universal Cannabis Symbol
JOIN
DONATE
Home
Supporting Kansas’ Medical Cannabis Program (SB 366)
Supporting Kansas’ Medical Cannabis Program (SB 366)
Rachel Knox, MD
Expert Testimony
|
October 23, 2019
|
Medical (cannabis)
Download PDF
</div></div><div class="socialshare blog"><div class="text-block-7"><strong>Share: </strong></div><div class="html-embed-7 w-embed"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A//dfcr.org/post/kansas-s-366-rachel-knox-md-october-2019" target="_blank" class="share-icon-wrap w-inline-block"><img loading="lazy" width="30" src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a5996d25fba25b1aa18a_facebook.png" alt="" class="social-media-icons"></a></div><div class="html-embed-7 w-embed"><a href="https://twitter.com/intent/tweet?text=https%3A//dfcr.org/post/kansas-s-366-rachel-knox-md-october-2019" target="_blank" class="share-icon-wrap w-inline-block"><img loading="lazy" width="30" src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a5997f7803a3b9c69bdd_twitter.png" alt="" class="social-media-icons"></a></div><div class="html-embed-7 w-embed"><a class="w-inline-block social-share-btn social-media-icons email" href="mailto:?subject=&body=:%20" target="_blank" title="Email" onclick="window.open('mailto:?subject=' + encodeURIComponent(document.title) + '&body=' + encodeURIComponent('https://dfcr.org/post/kansas-s-366-rachel-knox-md-october-2019')); return false;"><img loading="lazy" width="30" src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6194228b96c3d141b17766c4_email-svgrepo-com.svg" alt="" class="social-media-icons"></a></div></div><div class="divider"></div></div><div><h2>About the Author</h2><div class="w-row"><div class="w-col w-col-1"><img alt="Rachel Knox, MD" loading="lazy" width="140" src="https://cdn.prod.website-files.com/6140f19ec034b96f37445fa8/614ca91676abd1c685e4af8b_Knox_Headshot.jpg" class="image-6"/></div><div class="w-col w-col-11"><h3>Rachel Knox, MD</h3><div class="w-richtext"><p><a href="https://doctorsknox.com/dr-rachel"><strong>Rachel Knox, MD, MBA </strong></a>is an endocannabinologist specializing in cannabinoid medicine, and a policy expert on cannabis and psychedelic health equity. She’s the creator and president of the Cannabis Health Equity Movement (CHEM)™, comprising<a href="https://www.achemed.org/"> ACHEM–the Association for Cannabis Health Equity and Medicine</a>–and<a href="https://www.chemallyance.org/"> CHEM Allyance</a>; and is co-founder of Doctors Knox, Inc. and<a href="https://www.pivitaledu.com/"> Pivital Holdings</a>, a transformative life sciences company developing education and health solutions to improve well care access, promote health and data equity, and develop natural and botanical product innovations addressing stigmatized conditions in historically excluded communities. She is the immediate past chair of the Oregon Cannabis Commission, Equity Chair of the Oregon Psilocybin Advisory Board, a founding board member of<a href="https://www.crc-coalition.org/"> Cannabis Regulators of Color Coalition (CRCC)</a>, and member of the National Council on Federal Psychedelic Priorities (NCFPP).</p></div></div></div></div></div></div><div class="footer-section"><div class="content-section footer no-padding"><div class="container-wrapper-second footer"><div class="footer-block"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd.png" loading="lazy" width="286" sizes="(max-width: 479px) 83vw, (max-width: 767px) 41vw, (max-width: 991px) 29vw, (max-width: 1279px) 18vw, (max-width: 1919px) 222.2265625px, 286px" alt="D4DPR logo" srcset="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd-p-500.png 500w, https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd-p-800.png 800w, https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd-p-1080.png 1080w, https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd.png 1300w"/><div class="w-embed"><style> .image-container { text-align: center; } </style> <div class="image-container"> <a href="https://www.guidestar.org/profile/shared/ac11f4b2-d8c8-45e0-8006-58a23796b851" target="_blank"> <img src="https://widgets.guidestar.org/TransparencySeal/9511393" width="100" alt="Guidestar Transparency Seal"> </a> </div></div></div><div class="footer-block top"><h4 class="blog-tittle dark footer">Follow</h4><div class="div-block-25 w-clearfix"><a href="https://www.facebook.com/D4DPRorg/" Title="facebook" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a5996d25fba25b1aa18a_facebook.png" width="54" alt="Facebook" class="top-nav-icon"/></a><a href="https://twitter.com/d4dprorg" Title="Twitter" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a5997f7803a3b9c69bdd_twitter.png" width="49" alt="Twitter" class="top-nav-icon"/></a><a href="https://www.linkedin.com/company/d4dprorg/" Title="LinkedIn" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a59a8bfa9732bf790b6e_linkedin.png" width="40" alt="LinkedIn" class="top-nav-icon"/></a><a href="https://www.instagram.com/d4dprorg/" Title="Instagram" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a599335ab4511c5e6dd0_insta.png" width="53" alt="Instagram" class="top-nav-icon"/></a><a href="https://www.youtube.com/channel/UC7GLBo2PRDXuL8dzdQC2A3Q" Title="YouTube" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://cdn.prod.website-files.com/6140f19dc034b9b282445f9c/6169a708d0c8a4bd4cf361c6_youtube-svgrepo-com%20(1).svg" width="56" alt="YouTube" class="top-nav-icon"/></a></div></div><div class="footer-block contact"><h4 class="blog-tittle dark footer">Contact Us</h4><p><a href="mailto:info@d4dpr.org">info@d4dpr.org</a></p><p>Phone: (202) 930-0097</p><p>Doctors for Drug Policy Reform<br/>712 H Street NE, Suite 1290<br/>Washington, DC 20002</p></div><div class="footer-block third"><h4 class="blog-tittle dark footer">D4DPR News & Events</h4><a href="https://d4dpr.org/updates/media" class="link-block w-inline-block"><div class="text-block-4">Media</div></a><a href="/expert-testimony" class="link-block w-inline-block"><div class="text-block-4">Expert Testimony</div></a><a href="https://d4dpr.org/updates/education" class="link-block w-inline-block"><div class="text-block-4">Education</div></a><a href="https://d4dpr.org/updates/dfcr" class="link-block w-inline-block"><div class="text-block-4">D4DPR Updates</div></a></div><div class="footer-block fourth"><h4 class="blog-tittle dark footer">Sign Up for Our Newsletter!</h4><div class="html-embed-4 w-embed w-iframe"><iframe src="https://d4dpr.dm.networkforgood.com/forms/102955?iframe=1" width="100%" height="380px" frameborder="0">
©2024 Doctors for Cannabis Regulation, LLC DBA Doctors for Drug Policy Reform. All rights reserved.
